Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO +55.31% Days Sales Outstanding is 37.68 as of Jun. 2026, which is 44% above its 10-year median of 26.18. The stock has 1 warning sign investors should review. Among 201 Medical Diagnostics & Research companies, Invitro International ranks better than 91.04% on this metric.
The historical rank and industry rank for Invitro International's Days Sales Outstanding or its related term are showing as below:
IVRO'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.91 Med: 26.18 Max: 27.45
Current: 26.89
During the past 9 years, Invitro International's highest Days Sales Outstanding was 27.45. The lowest was 24.91. And the median was 26.18.
IVRO's Days Sales Outstanding is ranked better than 91.04% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.73
vs IVRO: 26.89
Invitro International's Days Sales Outstanding
increased
from Jun. 2025 (24.18) to Jun. 2026 (37.68).
Invitro International (OTCPK:IVRO) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Invitro International Days Sales Outstanding Related Terms
Invitro International Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Invitro International's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International Days Sales Outstanding Chart
IVRO vs IDTA, PRPH, NSTM: Days Sales Outstanding Comparison
For the Diagnostics & Research subindustry, Invitro International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Days Sales Outstanding vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Invitro International's Days Sales Outstanding falls into.
Invitro International Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International (IVRO) has a Days Sales Outstanding of 37.68 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Invitro International and its competitors. This is 44% above median its historical median of 26.18. Over the past decade, Invitro International's Days Sales Outstanding has ranged from 24.91 to 27.45. According to the industry distribution chart, Invitro International ranks #18 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 9%.
Is Invitro International's Days Sales Outstanding too high?
Invitro International's current Days Sales Outstanding of 37.68 is 44% above median its 10-year median of 26.18. Over the past 10 years, this metric has ranged from a low of 24.91 to a high of 27.45. The Medical Diagnostics & Research industry median Days Sales Outstanding is 67.73. Invitro International's value of 37.68 is 44.4% below this industry median. Based on the distribution chart, Invitro International ranks #18 out of 201 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Invitro International's Days Sales Outstanding compare to IDTA and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #18 out of 201 companies for Days Sales Outstanding. This places Invitro International in the top 9% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 67.73. Invitro International's value of 37.68 is 44.4% below this benchmark. Historically, Invitro International's own Days Sales Outstanding has ranged from 24.91 to 27.45 over the past decade. While the company's 10-year median is 26.18 vs. the industry median of 67.73, Invitro International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Diagnostics & Research company?
The median Days Sales Outstanding among Medical Diagnostics & Research companies is 67.73, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invitro International's current Days Sales Outstanding of 37.68 is 44.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Invitro International and its competitors. For the Medical Diagnostics & Research industry, the median Days Sales Outstanding is 67.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Days Sales Outstanding is 37.68, which is 44% above median its own 10-year median of 26.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 26.8% above its estimated fair value. The current Days Sales Outstanding is 37.68, which is 44% above median its 10-year median of 26.18 and 44.4% below the Medical Diagnostics & Research industry median of 67.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Invitro International (IVRO), the current Days Sales Outstanding is 37.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
